Floatz logo

Procarbazine

Primary Central Nervous System Lymphoma

Ono Pharmaceutical Co., Ltd.Small moleculePhase 3Active
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
59/ 100
Competitive Position
81/ 100

Competitive context

70 Active assets in the Primary Central Nervous System Lymphoma cohort.

Asset / SponsorPhaseRating
Etoposide
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase 4BBB
(+)-VINCRISTINE
Ono Pharmaceutical Co., Ltd.
Phase 4BBB
METHOTREXATE
Assistance Publique Hopitaux De Marseille
Phase 4BB
Adriamycin
Juan P. Alderuccio, MD
Phase 4BB
Idarubicin
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase 4BB

View all 50 →

Same molecule, other indications

Procarbazine is also rated in:

central nervous system neoplasmDormant
BBB
Indicative · Phase 3
75 / 100
View asset →
lymphomaActive
BB
Indicative · Phase 3
69 / 100
View asset →
toxic encephalopathyDormant
BB
Indicative · Phase 2
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →